Clinical Trials in Philadelphia

Showing 9881-9900 of 20,904 trials

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

NCT03578029

The objective of this study is to compare the efficacy and safety of RGN-137 topical gel with that of placebo gel for treatment of junctional epidermolysis bullosa (JEB) or dystrophic epidermolysis bullosa (DEB).

Junctional Epidermolysis BullosaDystrophic Epidermolysis Bullosa

Lenus Therapeutics, LLC4 participantsStarted May 2019

Evanston, Illinois, United States • Brooklyn, New York, United States • Cincinnati, Ohio, United States +2 more locations

COMPLETED< 1 mile

3T MRI CIED Post-Approval Study

NCT02969395

The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).

Cardiac Rhythm Disorder

Medtronic41 participantsStarted Apr 2016

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +201 more locations

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

3T MRI CIED Post-Approval Study

Find Trials by Condition in Philadelphia

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

DexCom Hospital Study-CGM Directed Insulin Delivery

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Open-Label Extension and Safety Study of Talazoparib

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Lenalidomide Monotherapy in R/R DLBCL

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Genomic Translation for Amyotrophic Lateral Sclerosis Care

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation